Piramal Enterprises Ltd (PEL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Piramal Enterprises Ltd (PEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011267
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd (PEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Piramal Enterprises Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Partnerships 12
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Imaging Enters into Partnership with Asan Medical 13
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 14
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Equity Offering 17
Piramal Enterprises Plans to Raise USD308 Million in Rights Offering of Shares 17
Piramal Enterprises Plans to Raise Funds through Public Offering 18
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 19
Debt Offering 20
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 20
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 21
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 22
Asset Transactions 23
Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 23
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 24
Acquisition 25
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 25
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 26
Piramal Enterprises Ltd – Key Competitors 27
Piramal Enterprises Ltd – Key Employees 28
Piramal Enterprises Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 32
Strategy And Business Planning 32
Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 32
Financial Announcements 33
Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 33
Feb 08, 2016: Piramal Enterprises Consolidated Results for the Q3 FY2016 and 9M FY2016 35
Corporate Communications 38
Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Piramal Enterprises Ltd, Medical Equipment, Key Facts, 2017 2
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Piramal Enterprises Ltd, Deals By Market, 2011 to YTD 2017 8
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Imaging Enters into Partnership with Asan Medical 13
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 14
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Piramal Enterprises Plans to Raise USD308 Million in Rights Offering of Shares 17
Piramal Enterprises Plans to Raise Funds through Public Offering 18
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 19
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 20
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 21
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 22
Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 23
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 24
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 25
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 26
Piramal Enterprises Ltd, Key Competitors 27
Piramal Enterprises Ltd, Key Employees 28
Piramal Enterprises Ltd, Other Locations 29
Piramal Enterprises Ltd, Subsidiaries 29

★海外企業調査レポート[Piramal Enterprises Ltd (PEL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arla Foods Ingredients Group P/S:戦略・SWOT・企業財務分析
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • AstraZeneca AB-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca Plc is a healthcare products provider that research and development of medicinal products. The company offers research and produces drug products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach …
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • DPR Construction, Inc.:企業の戦略・SWOT・財務情報
    DPR Construction, Inc. - Strategy, SWOT and Corporate Finance Report Summary DPR Construction, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Manulife Financial Corporation:企業の戦略・SWOT・財務情報
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Havila Shipping ASA (HAVI):石油・ガス:M&Aディール及び事業提携情報
    Summary Havila Shipping ASA (Havila) is a supplier of quality assured supply services to the international offshore industry. It owns and operates vessels and provides anchor handling, subsea construction, platform supply and multi-field rescue recovery services. The company’s fleet base includes an …
  • Rush Enterprises, Inc. (RUSHA):企業の財務・戦略的SWOT分析
    Rush Enterprises, Inc. (RUSHA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Torchlight Energy Resources Inc (TRCH):企業の財務・戦略的SWOT分析
    Summary Torchlight Energy Resources Inc (Torchlight Energy), formerly Known as Pole Perfect Studios Inc, is an oil and gas exploration and production company. The company’s activities include acquisition, exploration and development of domestic oil fields. Its business process includes investment ev …
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Grill Concepts, Inc.:企業の戦略・SWOT・財務情報
    Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Candover Investments plc (CDI):企業の財務・戦略的SWOT分析
    Candover Investments plc (CDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SPR Therapeutics LLC:製品パイプライン分析
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It also provides pe …
  • Calypso Biotech SA-製薬・医療分野:企業M&A・提携分析
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company’s pipeline products include CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody used in …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆